|
Sep 28
|
GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564
|
|
Jul 21
|
Should Value Investors Buy Grifols (GRFS) Stock?
|
|
Jul 20
|
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
|
|
Jul 18
|
Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis
|